Skip to main
HR

HR Stock Forecast & Price Target

HR Analyst Ratings

Based on 9 analyst ratings
Hold
Strong Buy 11%
Buy 22%
Hold 67%
Sell 0%
Strong Sell 0%

Bulls say

Healthcare Realty Trust is a strong investment opportunity due to its diversified portfolio, with 36 million square feet of medical office buildings in 20 core markets, and strong credit risk with rent coverage rivaling 10x. While the recent announcement of $1.5B of asset sales may have caused some initial volatility in the stock price, the company's ability to pay off debt and potentially engage in a $200M NCIB shows strong financial stability and potential for future growth. Despite some frustration with communication and process evolution, the stock remains a compelling "Buy" given its undervalued trading price and potential for successful capital recycling in the near future.

Bears say

Healthcare Realty Trust is making a significant move in its plan to become a Residential/Industrial REIT by selling $1.5B of Retail and Office assets at an 8.8% cap rate, which would impact its Q3/25A FFOPU by 21%. While this helps reduce debt and potentially open up the opportunity for NCIB unit purchases, the company has not yet provided enough detail on the remaining $1.1B of planned asset sales, and there may still be potential tax consequences in 2026. Overall, the outlook remains negative with projected declines in FFOPU and AFFOPU, and a revised AFFO payout ratio of 65%.

HR has been analyzed by 9 analysts, with a consensus rating of Hold. 11% of analysts recommend a Strong Buy, 22% recommend Buy, 67% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Healthcare Realty Trust Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Healthcare Realty Trust Inc (HR) Forecast

Analysts have given HR a Hold based on their latest research and market trends.

According to 9 analysts, HR has a Hold consensus rating as of May 5, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $18.89, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $18.89, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Healthcare Realty Trust Inc (HR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.